Science Explorer Back to mapMap
Discussion

Genogen (United States)

Research works
11
fractional, all time
Citations
632
57.3 per fractional work
Top-10% rate
10.2%
all institutions 10.0%
Open access
29%
world 40%
International
11%
world 18%

Not ranked overall: Genogen (United States) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does Genogen (United States) work in?

In all years, 64% of research at Genogen (United States) is in Health Sciences, 32% in Life Sciences. Its largest fields are Medicine (64%), Biochemistry, Genetics and Molecular Biology (23%), Immunology and Microbiology (9%). It does 1.8× the world's share of Health Sciences.

Health Sciences: 7 fractional works · 63.7% of its workMedicine: 7 fractional works · 63.7% of its workPulmonary and Respiratory Medicine: 4 fractional works · 31.9% of its workRadiology, Nuclear Medicine and Imaging: 1 fractional works · 9.6% of its workPediatrics, Perinatology and Child Health: 1 fractional works · 6.1% of its workAnesthesiology and Pain Medicine: 1 fractional works · 5.2% of its workPhysiology: 0 fractional works · 3.0% of its workPublic Health, Environmental and Occupational Health: 0 fractional works · 3.0% of its workOncology: 0 fractional works · 2.5% of its workHematology: 0 fractional works · 1.5% of its workCritical Care and Intensive Care Medicine: 0 fractional works · 1.0% of its workLife Sciences: 4 fractional works · 31.7% of its workBiochemistry, Genetics and Molecular Biology: 2 fractional works · 22.7% of its workMolecular Biology: 2 fractional works · 16.6% of its workGenetics: 0 fractional works · 4.5% of its workBiotechnology: 0 fractional works · 1.5% of its workImmunology and Microbiology: 1 fractional works · 9.1% of its workImmunology: 1 fractional works · 9.1% of its workPhysical Sciences: 0 fractional works · 4.5% of its workEngineering: 0 fractional works · 2.3% of its workElectrical and Electronic Engineering: 0 fractional works · 2.3% of its workPhysics and Astronomy: 0 fractional works · 1.5% of its workAtomic and Molecular Physics, and Optics: 0 fractional works · 1.5% of its workMaterials Science: 0 fractional works · 0.7% of its workElectronic, Optical and Magnetic Materials: 0 fractional works · 0.7% of its workALL ITS WORKGenogen (UnitedStates)11fractional works, all years
Life Sciences32%Physical Sciences5%Health Sciences64%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 3 domains and 6 fields, with their numbers
    1. Medicine763.7%
    1. Biochemistry, Genetics and Molecular Biology222.7%
    2. Immunology and Microbiology19.1%
    1. Engineering02.3%
    2. Physics and Astronomy01.5%
    3. Materials Science00.7%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

    What are the most cited papers from Genogen (United States)?

    The most cited paper from Genogen (United States) is "Aerosol Deposition in Neonatal Ventilation" (J.‐C. Dubus, Laurent Vecellio, Michèle De Monte et al., 2005), with 110 citations. Next come "Impact of Particle Size and Aerosolization Time on the Metabolic Effect of an Inhaled Insulin Aerosol" (14) and "Application of selective CVD tungsten for low contact resistance via filling to aluminum multilayer interconnection" (10).

    Most cited papers
    #PaperReleasedCitations
    1 Aerosol Deposition in Neonatal Ventilation J.‐C. Dubus, Laurent Vecellio, Michèle De Monte et al. · Pediatric Research 18 Mar 2005 110
    2 Impact of Particle Size and Aerosolization Time on the Metabolic Effect of an Inhaled Insulin Aerosol Christoph Kapitza, Tim Heise, Robert S. Fishman et al. · Diabetes Technology & Therapeutics Apr 2004 14
    3 Application of selective CVD tungsten for low contact resistance via filling to aluminum multilayer interconnection Sung Min Rang, Robert Hsiu-Ping Chow, Ronald H. Wilson et al. · Journal of Electronic Materials May 1988 10
    4 Flash quantum efficiency measurements for multi-junction solar cells Greg S. Horner, Leonid A. Vasilyev, Jan Schmidt et al. Conference paper Jun 2011 7
    All 4 most cited papers, with filters and sorting

    Which research topics does Genogen (United States) publish most on?

    By volume: Inhalation and Respiratory Drug Delivery, Monoclonal and Polyclonal Antibodies Research, Viral Infectious Diseases and Gene Expression in Insects and T-cell and B-cell Immunology.

    1. 1 Inhalation and Respiratory Drug Delivery Pulmonary and Respiratory Medicine 1 works
    2. 2 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 1 works
    3. 3 Viral Infectious Diseases and Gene Expression in Insects Molecular Biology 1 works
    4. 4 T-cell and B-cell Immunology Immunology 1 works
    5. 5 Neonatal Respiratory Health Research Pulmonary and Respiratory Medicine 1 works
    6. 6 Respiratory Support and Mechanisms Pulmonary and Respiratory Medicine 1 works
    7. 7 Airway Management and Intubation Techniques Anesthesiology and Pain Medicine 1 works
    8. 8 Animal Genetics and Reproduction Genetics 0 works
    9. 9 Cystic Fibrosis Research Advances Pulmonary and Respiratory Medicine 0 works
    10. 10 14-3-3 protein interactions Molecular Biology 0 works

    How open and international is its research?

    Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

    openly available28.7%not open71.3%

    World: 40% of research is openly available.

    with international co-authors10.9%domestic only89.1%

    World: 18% is written across borders.

    How has Genogen (United States)'s research output changed?

    19901995200020052010
    grewheldshrank

    The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

    Its share of all research

    Growing output can still be a shrinking share: all of science grows. This is Genogen (United States) as a percentage of every work published that year, 0.000010% in 2005.

    0.00010%0.00020%0.00030%Genogen (United States)0.0000078% in 2011199020002010

    Fractional works of Genogen (United States) over all fractional works that year. How the balance of science has shifted.

    Other research institutions in Mountain View

    All research institutions in Mountain View

    Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

    Discussion

    Ask a question or share a note about Genogen (United States). Posts are plain text and can be reported.